Oruka Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Other Noncurrent Assets of $25.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-10
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $0.00.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $0.00.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $60.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $60.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$6.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Oruka Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2021 was $6.00K, a 50.00% decline from fiscal 2020.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 5 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 8 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 11 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.00K 10-Q · filed 2026-08-10 | ||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $60.00K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $60.00K 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $60.00K 10-Q · filed 2026-08-10 | |||||
| 2025-03-31 | $60.00K 10-Q · filed 2026-05-13 | ||||||
| 2024-12-31 | $43.00K 10-K · filed 2026-03-12 | ||||||
| 2024-09-30 | $43.00K 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | $43.00K 10-Q · filed 2025-08-11 | ||||||
| 2023-12-31 | -$6.00K 10-K · filed 2024-02-01 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2024-02-01 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $6.00K 10-K · filed 2023-02-24 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $6.00K 10-Q · filed 2022-10-28 | |||||
| 2021-06-30 | $6.00K 10-Q · filed 2022-08-02 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $12.00K 10-K · filed 2022-03-14 | |||||
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-02 | ||||||
| 2016-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $129.00K derived: sum of 2 quarters · filed 2018-03-22 | $425.00K derived: sum of 3 quarters · filed 2018-03-22 | $432.00K 10-K · filed 2018-03-22 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $296.00K derived: sum of 2 quarters · filed 2017-11-09 | $303.00K 10-Q · filed 2017-11-09 | $285.00K derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $296.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $303.00K 10-Q · filed 2017-08-03 | $285.00K derived: sum of 3 quarters · filed 2017-08-03 | $290.00K derived: sum of 4 quarters · filed 2017-08-03 | |||
| 2016-03-31 | $7.00K 10-Q · filed 2017-05-15 | -$11.00K derived: sum of 2 quarters · filed 2017-05-15 | -$6.00K derived: sum of 3 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | -$13.00K derived: sum of 2 quarters · filed 2017-03-21 | $211.00K 10-K · filed 2017-03-21 | ||||
| 2015-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $229.00K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $224.00K 10-Q · filed 2016-08-09 | ||||||
| 2014-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $545.00K 10-K · filed 2016-03-17 | |||||
| 2014-09-30 | $452.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |